BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li XD, Shen H, Jiang JT, Zhang HZ, Zheng X, Shu YQ, Wu CP. Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer. World J Gastroenterol 2011; 17(8): 1082-1087 [PMID: 21448363 DOI: 10.3748/wjg.v17.i8.1082]
URL: https://www.wjgnet.com/1007-9327/full/v17/i8/1082.htm
Number Citing Articles
1
X. Wang, M. L. Wang, L. Y. Zhou, X. Y. Lu, J. F. Yang, H. G. Yu. Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancerClinical and Translational Oncology 2013; 15(10): 836 doi: 10.1007/s12094-013-1012-6
2
Changhua Zhang, Niranjan Awasthi, Margaret A. Schwarz, Stefan Hinz, Roderich E. Schwarz, Lu-Gang Yu. Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric CancerPLoS ONE 2013; 8(2): e58037 doi: 10.1371/journal.pone.0058037
3
N. Haj Mohammad, E. ter Veer, L. Ngai, R. Mali, M. G. H. van Oijen, H. W. M. van Laarhoven. Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysisCancer and Metastasis Reviews 2015; 34(3): 429 doi: 10.1007/s10555-015-9576-y
4
Xinjian Guo, Fuxing Zhao, Xinfu Ma, Guoshuang Shen, Dengfeng Ren, Fangchao Zheng, Feng Du, Ziyi Wang, Raees Ahmad, Xinyue Yuan, Junhui Zhao, Jiuda Zhao. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysisBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6294-9
5
Emil ter Veer, Nadia Haj Mohammad, Gert van Valkenhoef, Lok Lam Ngai, Rosa M. A. Mali, Maarten C. Anderegg, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysisJournal of the National Cancer Institute 2016; 108(10): djw166 doi: 10.1093/jnci/djw166
6
Bin Wu, Ming Ye, Huafeng Chen, Jinfang F. Shen. Costs of Trastuzumab in Combination With Chemotherapy for HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: An Economic Evaluation in the Chinese ContextClinical Therapeutics 2012; 34(2): 468 doi: 10.1016/j.clinthera.2012.01.012
7
Benjamin K. Gersten, Tracy S. Fitzgerald, Katharine A. Fernandez, Lisa L. Cunningham. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic AgentsJournal of the Association for Research in Otolaryngology 2020; 21(4): 303 doi: 10.1007/s10162-020-00759-y
8
Lok Lam Ngai, Emil ter Veer, Héctor G. van den Boorn, E. Hugo van Herk, Jessy Joy van Kleef, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. TOXview: a novel graphical presentation of cancer treatment toxicity profilesActa Oncologica 2019; 58(8): 1138 doi: 10.1080/0284186X.2019.1601256
9
Pankajini Mallick, Sumit Basu, Bhagavtula Moorthy, Romi Ghose. Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitroToxicology in Vitro 2017; 41: 75 doi: 10.1016/j.tiv.2017.02.019
10
Dan Zhang, Jia-Rui Wu, Xiao-Jiao Duan, Kai-Huan Wang, Yi Zhao, Meng-Wei Ni, Shu-Yu Liu, Xiao-Meng Zhang, Bing Zhang. A Bayesian Network Meta-Analysis for Identifying the Optimal Taxane-Based Chemotherapy Regimens for Treating Gastric CancerFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00717
11
Anna Dorothea Wagner, Nicholas LX Syn, Markus Moehler, Wilfried Grothe, Wei Peng Yong, Bee-Choo Tai, Jingshan Ho, Susanne Unverzagt. Chemotherapy for advanced gastric cancerCochrane Database of Systematic Reviews 2017; 2017(8) doi: 10.1002/14651858.CD004064.pub4
12
Yanzhi Bi, Dongxiang Zeng, Yizhong Dong, Guifeng Sheng, Honglei Song, Yang Ling. Weekly paclitaxel and S-1 combination chemotherapy for advanced gastric cancerThe Chinese-German Journal of Clinical Oncology 2013; 12(6): 273 doi: 10.1007/s10330-013-1145-7
13
Vincent T Janmaat, Ewout W Steyerberg, Ate van der Gaast, Ron HJ Mathijssen, Marco J Bruno, Maikel P Peppelenbosch, Ernst J Kuipers, Manon CW Spaander. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancerCochrane Database of Systematic Reviews 2017; 2017(11) doi: 10.1002/14651858.CD004063.pub4
14
Xiao-fan Luo, Ye-hao Luo, Xin-yi Zhao, Xue-ting Lin, Wen-ling Li, Jie Jie, Di Wu, Gang Fang, Yu-zhou Pang, An Huang. Application and progress of palliative therapy in advanced gastric carcinomasFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1104447